Carboplatin + Doxorubicin + Paclitaxel Combination

The combination of carboplatin, doxorubicin, and paclitaxel is a chemotherapy regimen used primarily for treating various types of cancer, particularly endometrial cancer. This combination leverages the different mechanisms of action of these three drugs to effectively target cancer cells. ## Mechanism of Action This combination therapy works through multiple mechanisms: - **Carboplatin**: A platinum-based chemotherapy drug that forms cross-links with DNA, interfering with DNA repair mechanisms and causing cell death. - **Doxorubicin**: An anthracycline antibiotic that intercalates with DNA and inhibits topoisomerase II, preventing DNA replication and transcription. - **Paclitaxel**: A taxane that stabilizes microtubules, preventing their breakdown during cell division and leading to cell death. Together, these drugs target cancer cells at different points in their life cycle, potentially increasing efficacy compared to single-agent therapy[1][2].